{"id":4232,"date":"2026-06-11T09:39:46","date_gmt":"2026-06-11T16:39:46","guid":{"rendered":"https:\/\/xpharma.com.cn\/?p=4232"},"modified":"2026-06-11T09:39:48","modified_gmt":"2026-06-11T16:39:48","slug":"createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure","status":"publish","type":"post","link":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/","title":{"rendered":"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure."},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">On June 11, the NMPA official website showed that the first innovative drug from Langlai Technology, Lanocopan Hydrochloride Tablets, was granted marketing approval through the priority review and approval procedure for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who have not previously received complement inhibitor therapy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Lanocopan Hydrochloride Tablets (development code: MY008211A) are a CFB inhibitor discovered and developed by Langlai Technology. In vitro mechanistic studies have shown that MY008211A can bind to CFB, effectively inhibiting complement pathway activation, thereby suppressing hemolysis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Buy <strong>MY008211A<\/strong><strong>&nbsp;<\/strong>from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On June 11, the NMPA official website showed that the first innovative drug from Langlai Technology, Lanocopan Hydrochloride Tablets, was granted marketing approval through the priority review and approval procedure for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who have not previously received complement inhibitor therapy. Lanocopan Hydrochloride Tablets (development code: MY008211A) [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":4233,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-4232","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China<\/title>\n<meta name=\"description\" content=\"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-\uff1amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China\" \/>\n<meta property=\"og:description\" content=\"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-\uff1amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/\" \/>\n<meta property=\"og:site_name\" content=\"Xpharma China\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/61590027634719\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-11T16:39:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-11T16:39:48+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-12_003838_971.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"231\" \/>\n\t<meta property=\"og:image:height\" content=\"231\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"xpharmanews\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Xpharma007\" \/>\n<meta name=\"twitter:site\" content=\"@Xpharma007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"xpharmanews\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/\"},\"author\":{\"name\":\"xpharmanews\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/person\\\/c292b26c0a3311036ce0f5ab28a1ea05\"},\"headline\":\"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure.\",\"datePublished\":\"2026-06-11T16:39:46+00:00\",\"dateModified\":\"2026-06-11T16:39:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/\"},\"wordCount\":132,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/\u5fae\u4fe1\u56fe\u7247_2026-06-12_003838_971.jpg\",\"articleSection\":[\"Approved News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/#respond\"]}]},{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/\",\"name\":\"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/\u5fae\u4fe1\u56fe\u7247_2026-06-12_003838_971.jpg\",\"datePublished\":\"2026-06-11T16:39:46+00:00\",\"dateModified\":\"2026-06-11T16:39:48+00:00\",\"description\":\"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/\u5fae\u4fe1\u56fe\u7247_2026-06-12_003838_971.jpg\",\"contentUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/\u5fae\u4fe1\u56fe\u7247_2026-06-12_003838_971.jpg\",\"width\":231,\"height\":231,\"caption\":\"Createrna\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\\\/\\\/xpharma.com.cn\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#website\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/\",\"name\":\"Xpharma China - International Pharmaceutical wholesaler and retailer\",\"description\":\"Xpharma China\",\"publisher\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xpharma.com.cn\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\",\"name\":\"Xpharma China\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo.gif\",\"contentUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo.gif\",\"width\":679,\"height\":166,\"caption\":\"Xpharma China\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/61590027634719\\\/\",\"https:\\\/\\\/x.com\\\/Xpharma007\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/person\\\/c292b26c0a3311036ce0f5ab28a1ea05\",\"name\":\"xpharmanews\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"caption\":\"xpharmanews\"},\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/author\\\/xpharmanews\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China","description":"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-\uff1amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/","og_locale":"en_US","og_type":"article","og_title":"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China","og_description":"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China","og_url":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-\uff1amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/","og_site_name":"Xpharma China","article_publisher":"https:\/\/www.facebook.com\/61590027634719\/","article_published_time":"2026-06-11T16:39:46+00:00","article_modified_time":"2026-06-11T16:39:48+00:00","og_image":[{"width":231,"height":231,"url":"http:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-12_003838_971.jpg","type":"image\/jpeg"}],"author":"xpharmanews","twitter_card":"summary_large_image","twitter_creator":"@Xpharma007","twitter_site":"@Xpharma007","twitter_misc":{"Written by":"xpharmanews","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/#article","isPartOf":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/"},"author":{"name":"xpharmanews","@id":"https:\/\/xpharma.com.cn\/#\/schema\/person\/c292b26c0a3311036ce0f5ab28a1ea05"},"headline":"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure.","datePublished":"2026-06-11T16:39:46+00:00","dateModified":"2026-06-11T16:39:48+00:00","mainEntityOfPage":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/"},"wordCount":132,"commentCount":0,"publisher":{"@id":"https:\/\/xpharma.com.cn\/#organization"},"image":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/#primaryimage"},"thumbnailUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-12_003838_971.jpg","articleSection":["Approved News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/#respond"]}]},{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/","url":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/","name":"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China","isPartOf":{"@id":"https:\/\/xpharma.com.cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/#primaryimage"},"image":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/#primaryimage"},"thumbnailUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-12_003838_971.jpg","datePublished":"2026-06-11T16:39:46+00:00","dateModified":"2026-06-11T16:39:48+00:00","description":"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure. - Xpharma China","breadcrumb":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/#primaryimage","url":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-12_003838_971.jpg","contentUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-12_003838_971.jpg","width":231,"height":231,"caption":"Createrna"},{"@type":"BreadcrumbList","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/createrna-%ef%bc%9amy008211-agranted-marketing-approval-through-priority-review-and-approval-procedure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/xpharma.com.cn\/"},{"@type":"ListItem","position":2,"name":"Createrna\u00a0\uff1aMY008211 agranted marketing approval through priority review and approval procedure."}]},{"@type":"WebSite","@id":"https:\/\/xpharma.com.cn\/#website","url":"https:\/\/xpharma.com.cn\/","name":"Xpharma China - International Pharmaceutical wholesaler and retailer","description":"Xpharma China","publisher":{"@id":"https:\/\/xpharma.com.cn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xpharma.com.cn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/xpharma.com.cn\/#organization","name":"Xpharma China","url":"https:\/\/xpharma.com.cn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xpharma.com.cn\/#\/schema\/logo\/image\/","url":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/04\/logo.gif","contentUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/04\/logo.gif","width":679,"height":166,"caption":"Xpharma China"},"image":{"@id":"https:\/\/xpharma.com.cn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/61590027634719\/","https:\/\/x.com\/Xpharma007"]},{"@type":"Person","@id":"https:\/\/xpharma.com.cn\/#\/schema\/person\/c292b26c0a3311036ce0f5ab28a1ea05","name":"xpharmanews","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","caption":"xpharmanews"},"url":"https:\/\/xpharma.com.cn\/index.php\/author\/xpharmanews\/"}]}},"_links":{"self":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/4232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/comments?post=4232"}],"version-history":[{"count":1,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/4232\/revisions"}],"predecessor-version":[{"id":4234,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/4232\/revisions\/4234"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/media\/4233"}],"wp:attachment":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/media?parent=4232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/categories?post=4232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/tags?post=4232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}